Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by 2seventy bio, Inc. 2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance September 25, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress August 07, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report Second Quarter 2024 Financial Results on August 7, 2024 August 05, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million June 26, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Participate in Upcoming Investor Conferences May 23, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress May 08, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024 May 03, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron April 01, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors March 20, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Progress March 05, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences March 01, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Participate in Upcoming Investor Conferences February 05, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces New Strategic Path Forward January 30, 2024 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Host Investor Call at 8:00am ET on Tuesday, December 12 to Discuss Data from KarMMa-3 and KarMMa-2 Studies of Abecma (idecabtagene vicleucel) December 11, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reiterates Commitment to Maximizing Shareholder Value December 06, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress November 14, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report Third Quarter 2023 Financial Results on November 14, 2023 November 10, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway September 12, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Participate in the 2023 Morgan Stanley Global Healthcare Conference September 06, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress August 14, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report Second Quarter 2023 Financial Results on August 14, 2023 August 08, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Clinical Study Pause of PLAT-08 Trial of SC-DARIC33 in Acute Myeloid Leukemia June 14, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Participate in Upcoming Investor Conference June 07, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Presents Broad Range of New Data Highlighting Novel Approaches Across its Cell Therapies Portfolio May 17, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Additional Data from KarMMa Studies of Abecma (idecabtagene vicleucel) at ASCO 2023 and EHA 2023 May 11, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports First Quarter Financial Results and Recent Operational Progress May 03, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 April 28, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Progress March 16, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio Announces Appointment of Wei Lin, M.D. to Board of Directors March 08, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT 2seventy bio to Participate in 43rd Annual TD Cowen Health Care Conference March 03, 2023 From 2seventy bio, Inc. Via Business Wire Tickers TSVT Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
